Previous close | 67.39 |
Open | 67.74 |
Bid | 67.40 x 0 |
Ask | 67.90 x 0 |
Day's range | 67.49 - 68.34 |
52-week range | 60.74 - 85.48 |
Volume | |
Avg. volume | 1,906,365 |
Market cap | 33.396B |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 30.82 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.92 (4.33%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | N/A |
UBS has downgraded Nutrien (NYSE:NTR) to a "neutral" rating from a "buy,” citing a weaker agricultural market outlook and diminishing free cash flow prospects. UBS analysts had previously expected that Nutrien's stock could recover as potash markets stabilized, but their latest earnings forecasts revealed a less optimistic scenario for the near term. UBS now expects Nutrien's earnings, particularly in its nitrogen and potash segments, to remain steady but with limited upside potential.
Altius Minerals Corp (ATUSF) reports a significant increase in net earnings despite challenges in EBITDA margins and cash flow.
Nutrien Ltd (NTR) reports robust first-half performance with a 17% increase in retail adjusted EBITDA, despite facing challenges in the Brazilian market and adjusting full-year guidance.